Allergy and Asthma Proceedings

The upper and lower airways: The epidemiological and pathophysiological connection
pp. 553-556(4)
Author: Slavin, Raymond G.

Allergic rhinitis and asthma connection: Treatment implications
pp. 557-564(8)
Author: Greenberger, Paul A.

Allergic rhinoconjunctivitis and differential diagnosis of the red eye
pp. 565-574(10)
Author: Granet, David

Indoor allergens, environmental avoidance, and allergic respiratory disease
pp. 575-579(5)
Author: Bush, Robert K.

Allergen immunotherapy and asthma: Efficacy, safety, and other considerations
pp. 580-589(10)
Author: Cox, Linda

Development and validation of an onset of effect questionnaire for patients with asthma
pp. 590-599(10)
Authors: Leidy, Nancy K.; Mathias, Susan D.; Parasuraman, Bhash M.; Patrick, Donald L.; Pathak, Dev

The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey
pp. 600-608(9)
Authors: Nathan, Robert A.; Meltzer, Eli O.; Derebery, Jennifer; Campbell, Ulka B.; Stang, Paul E.; Corrao, Marlo A.; Allen, Gina; Stanford, Richard

EG2 expressed by eosinophils as a clinically useful indicator of asthma
pp. 609-613(5)
Authors: Kamada, Yumiko; Kayaba, Hiroyuki; Ito, Wataru; Ueki, Sigeharu; Kobayashi, Yoshimi; Yamada, Yoshiyuki; Saito, Norihiro; Takahashi, Tomoe; Oyamada, Hajime; Chihara, Junichi

Gliadin-specific IgE in wheat-dependent exercise-induced anaphylaxis
pp. 614-621(8)
Authors: Lee, Jae-Young; Yoon, Sungho; Ye, Young-Min; Hur, Gyu Young; Kim, Seunghyun; Park, Hae-Sim

Oriental plane pollen allergy: Identification of allergens and cross-reactivity between relevant species
pp. 622-628(7)
Authors: Pazouki, Nazanin; Sankian, Mojtaba; Nejadsattari, Taher; Khavari-Nejad, Ramezan-Ali; Varasteh, Abdol-Reza

Prevalence of IgE reactivities in mold-allergic subjects to commercially available fungal enzymes
pp. 629-635(7)
Authors: Horner, W. Elliott; Armstrong, Maricelis; El-Dahr, Jane; McCants, Marjorie; Reese, Gerald; Kobernick, Aaron K.; Lehrer, Samuel B.

Use of olopatadine ophthalmic solution and reactivity of histamine skin testing
pp. 636-639(4)
Authors: Jones, Jeremy D.; Temino, Viviana M.; Dworski, Ryszard; Anderson, Cindy K.; Fahrenholz, John M.; An, Angel Qi

Rapid diagnosis of bacterial sinusitis in patients using a simple test of nasal secretions
pp. 640-643(4)
Authors: Huang, Shih-Wen; Small, Parker A.

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis
pp. 644-653(10)
Authors: Rosenwasser, Lanny J.; Mahr, Todd; Abelson, Mark B.; Gomes, Paul J.; Kennedy, Kathryn

Loratadine provides early symptom control in seasonal allergic rhinitis
pp. 654-658(5)
Authors: Kaiser, Harold B.; Gopalan, Gokul; Chung, Weiyuan

Comparative study of sensory attributes of two antihistamine nasal sprays: Olopatadine 0.6% and azelastine 0.1%
pp. 659-668(10)
Authors: Meltzer, Eli O.; Garadi, Rekha; LaForce, Craig; Chadwick, Stephen J.; Berger, William E.; Gross, Gary; Edwards, Michael R.; Crenshaw, Krista; Wall, G. Michael

Sinusitis and chronic progressive exercise-induced cough and dyspnea
pp. 669-675(7)
Authors: Williams, Adam N.; Simon, Ronald A.; Woessner, Katharine M.

Erratum for Yilmaz-Demirdag et al., Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4+ T-lymphocytopenia
pp. 675-675(1)

Erratum for Khorasani et al., The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease
pp. 675-675(1)

Research abstracts presented at the 46th annual scientific session of the Western Society of Allergy, Asthma, and Immunology
pp. 676-676(1)
Authors: Kaliner, MA; Storms, W; Javidi, M; Efessiou, C; Farrar, J